In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes. Bates ER. Ann Intern Med 2021;174:JC30.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bates ER. In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes. Ann Intern Med 2021;174:JC30.
PMID: 33646848